# US 2020/0002347 A1 · Macrocyclic compounds for treatment of medical disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0002347 A1
- Document ID: US20200002347A1
- Status: Published application
- Kind: A1
- Application number: 16/555,930
- Filed: 2019-08-29
- Published: 2020-01-02
- Earliest claimed: 2017-03-01
- Assignees: Achillion Pharmaceuticals, Inc.
- Applicants: Achillion Pharmaceuticals, Inc.
- Inventors: Jason Allan Wiles; Avinash S. Phadke; Dawei Chen; Venkat Rao Gadhachanda; Joel Charles Barrish; Atul Agarwal; Kyle J. Eastman
- Web page: https://patentgrep.com/patent/US20200002347A1

## CPC

- C07D 487/08: Bridged systems
- A61P 7/00: Drugs for disorders of the blood or the extracellular fluid
- A61P 7/02: Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A61P 31/12: Antivirals
- C07D 471/18: Bridged systems
- C07D 487/18: Bridged systems
- C07D 498/08: Bridged systems
- C07D 513/08: Bridged systems
- C07D 519/00: Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Macrocyclic Complement Factor D inhibitors, pharmaceutical compositions, and uses thereof, as well as processes for their manufacture are provided. The compounds provided include Formula I, Formula II, Formula III, Formula IV, Formula V, Formula VI, Formula VII, and Formula VIII or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide, or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade.

## Claims

### Claim 1

A compound selected from Formula:
or a pharmaceutically acceptable salt thereof;
wherein:
C2 is
X1 and X2 are independently N, CH, or CZ, wherein X1 is directly bound to L2 and X2 is directly bound to L1;
Q1 is N or C(R1), wherein Q1 is directly bound to X9;
Q2 is C(R2R2′);
Q3 is C(R3R3′);
Q4 is C(R1R1′);
Q5 is C(R2) or N wherein Q5 is directly bound to X9;
Q6 is N or C(R3), wherein Q6 is directly bound to X9;
Z is F, Cl, NH2, CH3, CH2D, CHD2, or CD3;
R1, R1′, R2, R2′, R3, and R3′ are independently selected from hydrogen, R201, halogen, hydroxyl, nitro, cyano, amino, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, C1-C6alkoxy, C2-C6alkanoyl, C1-C6alkylthio-, hydroxyC1-C6alkyl-, aminoC1-C6alkyl-, —C0-C4alkylNR9R10, —C(O)OR9, —OC(O)R9, —NR9C(O)R10, —C(O)NR9R10, —OC(O)NR9R10, —NR9C(O)OR10, —OR′, —NR′R″, C1-C6haloalkyl, and C1-C6haloalkoxy;
or R1 and R2 are taken together to form a 3-membered carbocyclic ring, a 4- to 6-membered carbocyclic or aryl ring, or a 4- to 6-membered heterocyclic or heteroaryl ring containing 1 or 2 heteroatoms independently selected from N, O, and S;
or R2 and R3 are taken together to form a 3- to 6-membered carbocyclic or aryl ring or a 3- to 6-membered heterocyclic or heteroaryl ring;
R′, and R″ are independently selected from H, R201, alkyl, cycloalkyl, cycloalkylalkyl, heterocycle, heterocycloalkyl, aryl, arylalkyl, heteroaryl, and heteroarylalkyl;
A1 is selected from:
L1 is a bond,
L2 is —C(O)—, —C(S)—, —P(O)OH—, —S(O)—, —S(O)2—, or —C(R52)2—;
L3 is
X3, X4, X5, X6, X7, and X8 are each independently selected from alkyl, bond, —C(R52)2—, —C(R52)2C(R52)2—, —C(R52)2C(R52)2C(R52)2—, —C(O)—, —C(S)—, —P(O)OR9—, —S(O)—, —S(O)2—, —O—, —S—, R201 in a divalent state, alkenylene, alkynylene, heterocycle, heteroalkylene, heteroalkynylene, heteroalkenylene, arylalkyl, heterocycloalkyl, heteroarylalkyl, aryl, heteroaryl, cycloalkyl, and —NR9—;
X9 and X10 are independently selected from alkylene, —C(R32)2—, —C(R52)2O—, —C(R52)2NR9—, —C(R52)2OC(O)—, —C(R52)2NR9C(O)—, —O—, —S—, —C(O)—, —C(S)—, —P(O)OR9—, —S(O)—, —S(O)2—, alkenylene, alkynylene, R201 in a divalent state, R32 in a divalent state, —NR9—, —CH2O—, —CH2N(H)—, —CH2OC(O)—, —CH2N(H)C(O)—, —CH2N(CH3)—, and —CH2N(CH3)C(O)—;
X11 is N or CR11;
X12 is N or CR12;
X13 is N or CR13,
X14 is N or CR14;
wherein no more than 2 of X11, X12, X13, and X14 are N;
R4, R5, and R6 are independently selected from hydrogen, halogen, —CHO, —C(O)NH2, —C2-C6alkanoyl, —C(O)NH(CH3), —COOH, —P(O)(OR9)2, —OC(O)R9, —C(O)OR9, nitro, hydroxyl, phenyl, 5- to 6-membered heteroaryl, cyano, amino, and C1-C6alkyl;
R7 is hydrogen, C0-C6alkyl, or —C0-C4alkyl(C3-C7cycloalkyl);
R8 and R8′ are independently selected from hydrogen, halogen, hydroxyl, C1-C6alkyl, —C0-C4alkyl(C3-C7cycloalkyl), C1-C6alkoxy, and (C1-C4alkylamino)C0-C2alkyl;
or R8 and R8′ are taken together to form an oxo group;
or R8 and R8′ or taken together to form a 3-membered carbocyclic ring;
R9 and R10 are independently selected at each occurrence from hydrogen, C1-C6alkyl, (C3-C7cycloalkyl)C0-C4alkyl, —C0-C4alkyl(C3-C7cycloalkyl), and —O—C0-C4alkyl(C3-C7cycloalkyl);
R11, R12, R13, and R14 are independently selected at each occurrence from hydrogen, R201, halogen, hydroxyl, nitro, cyano, —O(PO)(OR9)2, —(PO)(OR9)2, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, —C2-C6alkenyl-aryl, —C2-C6alkenyl-cycloalkyl, —C2-C6alkenyl-heterocycle, —C2-C6alkenyl-heteroaryl, C2-C6alkynyl, —C2-C6alkynyl-aryl, —C2-C6alkynyl-cycloalkyl, C2-C6alkynyl(heterocycle), —C2-C6alkynyl-heteroaryl, C2-C6alkanoyl, C1-C6alkoxy, C1-C6thioalkyl, —C0-C4alkyl(mono- and di-alkylamino), —C0-C4alkyl(C3-C7cycloalkyl), —C0-C4alkoxy(C3-C7cycloalkyl), C1-C6haloalkyl, C1-C6haloalkoxy, amino, —COOH, —C0-C4alkyl(C3-C7cycloalkyl), C2-C6alkenyloxy, —C(O)OR9, C0-C4alkylNR9R10, —C(O)NR9R10, —SO2R9, —SO2NR9R10, —OC(O)R9, —C(NR9)NR9R10, and R32, each of which other than hydrogen, halogen, hydroxyl, nitro, cyano, haloalkyl, and haloalkoxy is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, amino, —COOH, —CONH2, C1-C6haloalkyl, C0-C6haloalkoxy, phenyl, 4- to 7-membered heterocycle containing 1, 2, or 3 heteroatoms independently selected from N, O, and S, each of which phenyl or 4- to 7-membered heterocycle is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, C1-C6alkyl, C2-C6alkenyl, C2-C6alkanoyl, C1-C6alkoxy, (mono- and di-alkylamino)C0-C4alkyl, C1-C6alkylester, —C0-C4alkyl(C3-C7cycloalkyl), C1-C6haloalkyl, and C1-C6haloalkoxy;
R17 is hydrogen, C1-C6alkyl, or —C0-C4alkyl(C3-C7cycloalkyl);
R18 and R18′ are independently selected from hydrogen, halogen, hydroxymethyl, and methyl;
R21 and R22 are independently selected from hydrogen, hydroxyl, cyano, amino, C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxy, (C3-C7cycloalkyl)C0-C4alkyl, (phenyl)C0-C4alkyl, —C1-C4alkylOC(O)OC1-C6alkyl, —C1-C4alkylOC(O)C1-C6alkyl, —C1-C4alkylC(O)OC1-C6alkyl, (4- to 7-membered heterocycloalkyl)C0-C4alkyl having 1, 2, or 3 heteroatoms independently selected from N, O, and S, and (5- or 6-membered unsaturated or aromatic heterocycle)C0-C4alkyl having 1, 2, or 3 heteroatoms independently selected from N, O, and S;
or R21 and R22 can be taken together to form a carbocyclic or heterocyclic ring;
R23 is independently selected from C1-C6alkyl, C1-C6haloalkyl, (aryl)C0-C4alkyl, (C3-C7cycloalkyl)C0-C4alkyl, (phenyl)C0-C4alkyl, (4- to 7-membered heterocycloalkyl)C0-C4alkyl having 1, 2, or 3 heteroatoms independently selected from N, O, and S, and (5- or 6-membered unsaturated or aromatic heterocycle)C0-C4alkyl having 1, 2, or 3 heteroatoms independently selected from N, O, and S;
R24 and R25 are taken together with the nitrogen to which they are attached to form a 4- to 7-membered monocyclic heterocycloalkyl group, or a 6- to 10-membered bicyclic heterocyclic group having fused, spiro, or bridged rings;
R32 is selected from hydrogen, aryl, heteroaryl, and heterocycle wherein the aryl, heteroaryl, and heterocycle can be optionally substituted with 1, 2, 3, or 4 substituents independently selected from halogen, hydroxyl, amino, cyano, —CHO, —COOH, —CONH2, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, C1-C6alkoxy, C2-C6alkanoyl, C1-C6alkylester, (mono- and di-C1-C6alkylamino)C0-C2alkyl, C1-C6haloalkyl, hydoxyC1-C6alkyl, —C0-C6alkyl-heterocycle, —C0-C6alkyl-heteroaryl, C0-C6haloalkoxy, and R201;
B2 is a heteroaryl, heterocycle, or aryl group directly bound to both L1 and X10 at two independent positions;
wherein, each of which B2 is optionally substituted with one or more substituents independently selected from R33, R34, R35, R36, and R201;
R33 is independently selected from halogen, hydroxyl, —COOH, cyano, C1-C6alkyl, C2-C6alkanoyl, C1-C6alkoxy, —C0-C4alkylNR9R10, —SO2R9, C1-C6haloalkyl, and C1-C6haloalkoxy;
R34 is independently selected from nitro, C2-C6alkenyl, C2-C6alkynyl, C1-C6thioalkyl, -JC3-C7cycloalkyl, —B(OH)2, -JC(O)NR9R23, -JOSO2OR21, —C(O)(CH2)1-4S(O)R21, —O(CH2)1-4S(O)NR21R22, -JOP(O)(OR21)(OR22), -JP(O)OR21)(OR22), -JOP(O)(OR21)R22, -JP(O)(OR21)R22, -JOP(O)R21R22, -JP(O)R21R22, -JSP(O)(OR21)(OR22), -JSP(O)(OR21)(R22), -JSP(O)(R21)(R22), -JNR9P(O)(NHR21)(NHR22), -JNR9P(O)(OR21)(NHR22), -JNR9P(O)(OR21)(OR22), -JC(S)R21, -JNR21SO2R22, -JNR9S(O)NR10R22, -JNR9SO2NR10R22, -JSO2NR9COR22, -JSO2NR9CONR21R22, -JNR21SO2R22, -JC(O)NR21SO2R22, -JC(NH2)═NR22, -JCH(NH2)NR9S(O)2R22, -JOC(O)NR21R22, -JNR21C(O)OR22, -JNR21OC(O)R22, —(CH2)1-4C(O)NR21R22, -JC(O)R24R25, -JNR9C(O)R21, -JC(O)R21, -JNR9C(O)NR10R22, —CCR21, —(CH2)1-4OC(O)R21, and -JC(O)OR23; each of which R34 is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, amino, oxo, —B(OH)2, —Si(CH3)3, —COOH, —CONH2, —P(O)(OH)2, C1-C6alkyl, —C0-C4alkyl(C3-C7cycloalkyl), C1-C6alkoxy, —C0-C2alkyl(mono- and di-C1-C4alkylamino), C1-C6alkylester, C1-C4alkylamino, C1-C4hydroxylalkyl, C1-C6haloalkyl, and C1-C6haloalkoxy;
R35 is independently selected from naphthyl, naphthyloxy, indanyl, (4- to 7-membered heterocycloalkyl)C0-C4alkyl containing 1 or 2 heteroatoms selected from N, O, and S, and bicyclic heterocycle containing 1, 2, or 3 heteroatoms independently selected from N, O, and S, and containing 4- to 7-ring atoms in each ring; each of which R35 is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, C1-C6alkyl, C2-C6alkenyl, C2-C6alkanoyl, C1-C6alkoxy, (mono- and di-alkylamino)C0-C4alkyl, C1-C6alkylester, —C0-C4alkyl(C3-C7cycloalkyl), —SO2R9, C0-C6haloalkyl, and C1-C6haloalkoxy;
R36 is independently selected from tetrazolyl, (phenyl)C0-C2alkyl, (phenyl)C1-C6alkoxy, phenoxy, and heteroaryl containing 1, 2, or 3 heteroatoms independently selected from N, O, B, and S, each of which R36 is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, C1-C6alkyl, C2-C6alkenyl, C2-C6alkanoyl, C1-C6alkoxy, (mono- and di-alkylamino)C0-C4alkyl, C1-C6alkylester, —C0-C4alkyl(C3-C7cycloalkyl), —SO2R9, —OSi(CH3)2C(CH3)3, —Si(CH3)2C(CH3)3, C1-C6haloalkyl, and C1-C6haloalkoxy;
R52 is independently selected from halo, hydrogen, or C1-C6alkyl, amino, hydroxyl, aminoalkyl, alkenyl, alkynyl, C2-C6alkenyl(aryl), C2-C6alkenyl(cycloalkyl), C2-C6alkenyl(heterocycle), C2-C6alkenyl(heteroaryl), alkynyl, C2-C6alkynyl(aryl), C2-C6alkynyl(cycloalkyl), C2-C6alkynyl(heterocycle), C2-C6alkynyl(heteroaryl), alkanoyl, C1-C6alkoxy, C1-C6thioalkyl, —C0-C4alkyl(mono- and di-alkylamino), —C0-C4alkyl(C3-C7cycloalkyl), —C0-C4alkoxy(C3-C7cycloalkyl), haloalkyl, haloalkoxy, —COOH, —C0-C4alkyl(C3-C7-cycloalkyl), C2-C6alkenyloxy, —C(O)OR9, —C0-C4alkylNR9R10, —C(O)NR9R10, —SO2R9, —SO2NR9R10, —OC(O)R9, R201, and N(R9)C(O)R10;
or two R52 groups can be taken together to form an oxo or alkene group;
or two R52 groups can be taken together to form a 3- to 6-membered carbocyclic spiro ring or a 3- to 6-membered heterocyclic spiro ring containing 1 or 2 heteroatoms independently selected from N, O, or S;
R201 is selected from aminoalkyl-, alkylaminoalkyl-, heterocycloalkyl-, hydroxyalkyl, -alkyl-O-alkyl, -alkyl-S-alkyl, -alkyl-N(alkyl)-alkyl, -alkyl-NH-alkyl, -aliphatic-O-aliphatic, -aliphatic-S-aliphatic, -aliphatic-N(aliphatic)-aliphatic, -aliphatic-NH-aliphatic, -aliphatic-O-heterocycle, -aliphatic-S-heterocycle, -aliphatic-N(aliphatic)-heterocycle, -aliphatic-NH-heterocycle, -alkyl-NHC(O)haloalkyl, -alkyl-NR9C(O)haloalkyl, -alkyl-C(O)NHhaloalkyl, -alkyl-C(O)NR9haloalkyl, -alkyl-NHC(O)haloalkyl, -alkyl-NR9C(O)aliphatic, -alkyl-C(O)NHaliphatic, -alkyl-NR9C(O)aliphatic, -alkyl-NHC(O)aliphatic, alkyl-O-haloalkyl, alkyl-heteroaryl, heteroaryl, heterocycle, alkyl-heterocycle, and —N(aliphatic)2;
J is independently selected from a covalent bond, C1-C4alkylene, —OC1-C4alkylene, C2-C4alkenylene, and C2-C4alkynylene; and
m is 0, 1, 2, or 3.

### Claim 2 (depends on 1)

The compound of claim 1, wherein R32 is

### Claim 3 (depends on 1)

The compound of claim 1, wherein X9-L3-X10 or X10-L3-X9 is selected from:

### Claim 4 (depends on 1)

The compound of claim 1, wherein X9-L3-X10 or X10-L3-X9 is selected from:

### Claim 5 (depends on 1)

The compound of claim 1, wherein B2 is a six membered heteroaryl substituted with 1 or 2 groups selected from R33.

### Claim 6 (depends on 1)

A pharmaceutical composition comprising a compound of claim 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

### Claim 7

A compound selected from Formula:
or a pharmaceutically acceptable salt thereof;
wherein:
C2 is
X1 and X2 are independently N, CH, or CZ, wherein X1 is directly bound to L2 and X2 is directly bound to L1;
Q1 is N or C(R1), wherein Q1 is directly bound to X9;
Q2 is C(R2R2′);
Q3 is C(R3R3′);
Q4 is C(R1R1′);
Q5 is C(R2) or N wherein Q5 is directly bound to X9;
Q6 is N or C(R3), wherein Q6 is directly bound to X9;
Z is F, Cl, NH2, CH3, CH2D, CHD2, or CD3;
R1, R1′, R2, R2′, R3, and R3′ are independently selected from hydrogen, R201, halogen, hydroxyl, nitro, cyano, amino, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, C1-C6alkoxy, C2-C6alkanoyl, C1-C6alkylthio-, hydroxyC1-C6alkyl-, aminoC1-C6alkyl-, —C0-C4alkylNR9R10, —C(O)OR9, —OC(O)R9, —NR9C(O)R10, —C(O)NR9R10, —OC(O)NR9R10, —NR9C(O)OR10, —OR′, —NR′R″, C1-C6haloalkyl, and C1-C6haloalkoxy;
or R1 and R2 are taken together to form a 3-membered carbocyclic ring, a 4- to 6-membered carbocyclic or aryl ring, or a 4- to 6-membered heterocyclic or heteroaryl ring containing 1 or 2 heteroatoms independently selected from N, O, and S;
or R2 and R3 are taken together to form a 3- to 6-membered carbocyclic or aryl ring or a 3- to 6-membered heterocyclic or heteroaryl ring;
R′, and R″ are independently selected from H, R201, alkyl, cycloalkyl, cycloalkylalkyl, heterocycle, heterocycloalkyl, aryl, arylalkyl, heteroaryl, and heteroarylalkyl;
A2 is selected from:
X51, X52, X53 and X51 are selected from N, CR13, and a carbon directly bound to X10, wherein one and only one of X51, X52, X53 and X54 is a carbon directly bound to X10;
L1 is a bond,
L2 is —C(O)—, —C(S)—, —P(O)OH—, —S(O)—, —S(O)2—, or —C(R52)2—;
L3 is
X3, X4, X5, X6, X7, and X8 are each independently selected from alkyl, bond, —C(R52)2—, —C(R52)2C(R52)2—, —C(R52)2C(R52)2C(R52)2—, —C(O)—, —C(S)—, —P(O)OR9—, —S(O)—, —S(O)2—, —O—, —S—, R201 in a divalent state, alkenylene, alkynylene, heterocycle, heteroalkylene, heteroalkynylene, heteroalkenylene, arylalkyl, heterocycloalkyl, heteroarylalkyl, aryl, heteroaryl, cycloalkyl, and —NR9—;
X9 and X10 are independently selected from alkylene, —C(R5)2−, —C(R52)2O—, —C(R52)2NR9—, —C(R52)2OC(O)—, —C(R52)2NR9C(O)—, —O—, —S—, —C(O)—, —C(S)—, —P(O)OR9—, —S(O)—, —S(O)2—, alkenylene, alkynylene, R201 in a divalent state, R32 in a divalent state, —NR9—, —CH2O—, —CH2N(H)—, —CH2OC(O)—, —CH2N(H)C(O)—, —CH2N(CH3)—, and —CH2N(CH3)C(O)—;
R4, R5, and R6 are independently selected from hydrogen, halogen, —CHO, —C(O)NH2, —C2-C6alkanoyl, —C(O)NH(CH3), —COOH, —P(O)(OR9)2, —OC(O)R9, —C(O)OR9, nitro, hydroxyl, phenyl, 5- to 6-membered heteroaryl, cyano, amino, and C1-C6alkyl;
R7 is hydrogen, C1-C6alkyl, or —C0-C4alkyl(C3-C7cycloalkyl);
R8 and R8′ are independently selected from hydrogen, halogen, hydroxyl, C1-C6alkyl, —C0-C4alkyl(C3-C7cycloalkyl), C1-C6alkoxy, and (C1-C4alkylamino)C0-C2alkyl;
or R8 and R8′ are taken together to form an oxo group;
or R8 and R8′ or taken together to form a 3-membered carbocyclic ring;
R9 and R10 are independently selected at each occurrence from hydrogen, C1-C6alkyl, (C3-C7cycloalkyl)C0-C4alkyl, —C0-C4alkyl(C3-C7cycloalkyl), and —O—C0-C4alkyl(C3-C7cycloalkyl);
R13 is independently selected at each occurrence from hydrogen, R201, halogen, hydroxyl, nitro, cyano, —O(PO)(OR9)2, —(PO)(OR9)2, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, —C2-C6alkenyl-aryl, —C2-C6alkenyl-cycloalkyl, —C2-C6alkenyl-heterocycle, —C2-C6alkenyl-heteroaryl, C2-C6alkynyl, —C2-C6alkynyl-aryl, —C2-C6alkynyl-cycloalkyl, C2-C6alkynyl(heterocycle), —C2-C6alkynyl-heteroaryl, C2-C6alkanoyl, C1-C6alkoxy, C1-C6thioalkyl, —C0-C4alkyl(mono- and di-alkylamino), —C0-C4alkyl(C3-C7cycloalkyl), —C0-C4alkoxy(C3-C7cycloalkyl), C1-C6haloalkyl, C1-C6haloalkoxy, amino, —COOH, —C0-C4alkyl(C3-C7cycloalkyl), C2-C6alkenyloxy, —C(O)OR9, C0-C4alkylNR9R10, —C(O)NR9R10, —SO2R9, —SO2NR9R10, —OC(O)R9, —C(NR9)NR9R10, and R32, each of which other than hydrogen, halogen, hydroxyl, nitro, cyano, haloalkyl, and haloalkoxy is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, amino, —COOH, —CONH2, C1-C6haloalkyl, C1-C6haloalkoxy, phenyl, 4- to 7-membered heterocycle containing 1, 2, or 3 heteroatoms independently selected from N, O, and S, each of which phenyl or 4- to 7-membered heterocycle is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, C1-C6alkyl, C2-C6alkenyl, C2-C6alkanoyl, C1-C6alkoxy, (mono- and di-alkylamino)C0-C4alkyl, C1-C6alkylester, —C0-C4alkyl(C3-C7cycloalkyl), C1-C6haloalkyl, and C1-C6haloalkoxy;
R17 is hydrogen, C1-C6alkyl, or —C0-C4alkyl(C3-C7cycloalkyl);
R18 and R18′ are independently selected from hydrogen, halogen, hydroxymethyl, and methyl;
R21 and R22 are independently selected from hydrogen, hydroxyl, cyano, amino, C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxy, (C3-C7cycloalkyl)C0-C4alkyl, (phenyl)C0-C4alkyl, —C0-C4alkylOC(O)OC1-C6alkyl, —C1-C4alkylOC(O)C1-C6alkyl, —C1-C4alkylC(O)OC1-C6alkyl, (4- to 7-membered heterocycloalkyl)C0-C4alkyl having 1, 2, or 3 heteroatoms independently selected from N, O, and S, and (5- or 6-membered unsaturated or aromatic heterocycle)C0-C4alkyl having 1, 2, or 3 heteroatoms independently selected from N, O, and S;
or R21 and R22 can be taken together to form a carbocyclic or heterocyclic ring;
R23 is independently selected from C1-C6alkyl, C1-C6haloalkyl, (aryl)C0-C4alkyl, (C3-C7cycloalkyl)C0-C4alkyl, (phenyl)C0-C4alkyl, (4- to 7-membered heterocycloalkyl)C0-C4alkyl having 1, 2, or 3 heteroatoms independently selected from N, O, and S, and (5- or 6-membered unsaturated or aromatic heterocycle)C0-C4alkyl having 1, 2, or 3 heteroatoms independently selected from N, O, and S;
R24 and R25 are taken together with the nitrogen to which they are attached to form a 4- to 7-membered monocyclic heterocycloalkyl group, or a 6- to 10-membered bicyclic heterocyclic group having fused, spiro, or bridged rings;
R32 is selected from hydrogen, aryl, heteroaryl, and heterocycle wherein the aryl, heteroaryl, and heterocycle can be optionally substituted with 1, 2, 3, or 4 substituents independently selected from halogen, hydroxyl, amino, cyano, —CHO, —COOH, —CONH2, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, C1-C6alkoxy, C2-C6alkanoyl, C1-C6alkylester, (mono- and di-C1-C6alkylamino)C0-C2alkyl, C1-C6haloalkyl, hydoxyC1-C6alkyl, —C0-C6alkyl-heterocycle, —C0-C6alkyl-heteroaryl, C1-C6haloalkoxy, and R201;
B1 is heteroaryl, heterocycle, aryl, monocyclic or bicyclic carbocycle, C2-C6alkenyl, C2-C6alkynyl, biphenyl, or alkyl; wherein, each of which B1 is optionally substituted with one or more substituents independently selected from R33, R34, R35, R36, and R201;
R33 is independently selected from halogen, hydroxyl, —COOH, cyano, C1-C6alkyl, C2-C6alkanoyl, C1-C6alkoxy, —C0-C4alkylNR9R10, —SO2R9, C1-C6haloalkyl, and C1-C6haloalkoxy;
R34 is independently selected from nitro, C2-C6alkenyl, C2-C6alkynyl, C1-C6thioalkyl, -JC3-C7cycloalkyl, —B(OH)2, -JC(O)NR9R23, -JOSO2OR21, —C(O)(CH2)1-4S(O)R21, —O(CH2)1-4S(O)NR21R22, -JOP(O)(OR21)(OR22), -JP(O)(OR21)(OR22), -JOP(O)(OR21)R22, -JP(O)(OR21)R22, -JOP(O)R21R22, -JP(O)R21R22, -JSP(O)(OR21)(OR22), -JSP(O)(OR21)(R22), -JSP(O)(R21)(R22), -JNR9P(O)(NHR21)(NHR22), -JNR9P(O)(OR21)(NHR22), -JNR9P(O)(OR21)(OR22), -JC(S)R21, -JNR21SO2R22, -JNR9S(O)NR10R22, -JNR9SO2NR10R22, -JSO2NR9COR22, -JSO2NR9CONR21R22, -JNR21SO2R22, -JC(O)NR21SO2R22, -JC(NH2)═NR22, -JCH(NH2)NR9S(O)2R22, -JOC(O)NR21R22, -JNR21C(O)OR22, -JNR21OC(O)R22, —(CH2)1-4C(O)NR21R22, -JC(O)R24R25, -JNR9C(O)R21, -JC(O)R21, -JNR9C(O)NR10R22, —CCR21, —(CH2)1-4OC(O)R21, and -JC(O)OR23; each of which R34 is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, amino, oxo, —B(OH)2, —Si(CH3)3, —COOH, —CONH2, —P(O)(OH)2, C1-C6alkyl, —C0-C4alkyl(C3-C7cycloalkyl), C1-C6alkoxy, —C0-C2alkyl(mono- and di-C1-C4alkylamino), C1-C6alkylester, C1-C4alkylamino, C1-C4hydroxylalkyl, C1-C6haloalkyl, and C1-C6haloalkoxy;
R35 is independently selected from naphthyl, naphthyloxy, indanyl, (4- to 7-membered heterocycloalkyl)C0-C4alkyl containing 1 or 2 heteroatoms selected from N, O, and S, and bicyclic heterocycle containing 1, 2, or 3 heteroatoms independently selected from N, O, and S, and containing 4- to 7-ring atoms in each ring; each of which R35 is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, C1-C6alkyl, C2-C6alkenyl, C2-C6alkanoyl, C1-C6alkoxy, (mono- and di-alkylamino)C0-C4alkyl, C1-C6alkylester, —C0-C4alkyl(C3-C7cycloalkyl), —SO2R9, C1-C6haloalkyl, and C1-C6haloalkoxy;
R36 is independently selected from tetrazolyl, (phenyl)C0-C2alkyl, (phenyl)C1-C6alkoxy, phenoxy, and heteroaryl containing 1, 2, or 3 heteroatoms independently selected from N, O, B, and S, each of which R36 is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, C1-C6alkyl, C2-C6alkenyl, C2-C6alkanoyl, C1-C6alkoxy, (mono- and di-alkylamino)C0-C4alkyl, C1-C6alkylester, —C0-C4alkyl(C3-C7cycloalkyl), —SO2R9, —OSi(CH3)2C(CH3)3, —Si(CH3)2C(CH3)3, C1-C6haloalkyl, and C1-C6haloalkoxy;
R52 is independently selected from halo, hydrogen, or C1-C6alkyl, amino, hydroxyl, aminoalkyl, alkenyl, alkynyl, C2-C6alkenyl(aryl), C2-C6alkenyl(cycloalkyl), C2-C6alkenyl(heterocycle), C2-C6alkenyl(heteroaryl), alkynyl, C2-C6alkynyl(aryl), C2-C6alkynyl(cycloalkyl), C2-C6alkynyl(heterocycle), C2-C6alkynyl(heteroaryl), alkanoyl, C1-C6alkoxy, C1-C6thioalkyl, —C0-C4alkyl(mono- and di-alkylamino), —C0-C4alkyl(C3-C7cycloalkyl), —C0-C4alkoxy(C3-C7cycloalkyl), haloalkyl, haloalkoxy, —COOH, —C0-C4alkyl(C3-C7cycloalkyl), C2-C6alkenyloxy, —C(O)OR9, —C0-C4alkylNR9R10, —C(O)NR9R10, —SO2R9, —SO2NR9R10, —OC(O)R9, R201, and N(R9)C(O)R10;
or two R52 groups can be taken together to form an oxo or alkene group;
or two R52 groups can be taken together to form a 3- to 6-membered carbocyclic spiro ring or a 3- to 6-membered heterocyclic spiro ring containing 1 or 2 heteroatoms independently selected from N, O, or S;
R201 is selected from aminoalkyl-, alkylaminoalkyl-, heterocycloalkyl-, hydroxyalkyl, -alkyl-O-alkyl, -alkyl-S-alkyl, -alkyl-N(alkyl)-alkyl, -alkyl-NH-alkyl, -aliphatic-O-aliphatic, -aliphatic-S-aliphatic, -aliphatic-N(aliphatic)-aliphatic, -aliphatic-NH-aliphatic, -aliphatic-O-heterocycle, -aliphatic-S-heterocycle, -aliphatic-N(aliphatic)-heterocycle, -aliphatic-NH-heterocycle, -alkyl-NHC(O)haloalkyl, -alkyl-NR9C(O)haloalkyl, -alkyl-C(O)NHhaloalkyl, -alkyl-C(O)NR9haloalkyl, -alkyl-NHC(O)haloalkyl, -alkyl-NR9C(O)aliphatic, -alkyl-C(O)NHaliphatic, -alkyl-NR9C(O)aliphatic, -alkyl-NHC(O)aliphatic, alkyl-O-haloalkyl, alkyl-heteroaryl, heteroaryl, heterocycle, alkyl-heterocycle, and —N(aliphatic)2;
J is independently selected from a covalent bond, C1-C4alkylene, —OC1-C4alkylene, C2-C4alkenylene, and C2-C4alkynylene; and
m is 0, 1, 2, or 3.

### Claim 8 (depends on 7)

The compound of claim 7, wherein R32 is

### Claim 9 (depends on 7)

The compound of claim 7, wherein X9-L3-X10 or X10-L3-X9 is selected from:

### Claim 10 (depends on 7)

The compound of claim 7, wherein X9-L3-X10 or X10-L3-X9 is selected from:

### Claim 11 (depends on 7)

The compound of claim 7, wherein B1 is a six membered heteroaryl substituted with 1, 2, or 3 groups selected from R33.

### Claim 12 (depends on 7)

A pharmaceutical composition comprising a compound of claim 7 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

### Claim 13 (depends on 7)

The compound of claim 7 of formula
wherein # is 3, 4, 5, 6, 7, 8, 9, or 10;
or a pharmaceutically acceptable salt thereof.

### Claim 14

A compound selected from Formula:
or a pharmaceutically acceptable salt thereof;
wherein:
L5 is selected from L3 and L4;
Y9 is selected from X9 and Z9;
Y10 is selected from X10 and Z10;
wherein at least one of the following is true:
a. L5 is L4;
b. Y9 is Z9; or
c. Y10 is Z10;
Z9 is —CO—, —S(O)2—, or —S(O)—;
Z10 is —CO— or —S(O)—;
L4 is
X101 is selected from —CR52aR52—, —C(O)—, —C(S)—, —P(O)OR9—, —S(O)—, —S(O)2—, —O—, —S—, alkenylene, alkynylene, heterocycle, heteroalkylene, heteroalkynylene, heteroalkenylene, arylalkyl, heterocycloalkyl, heterocycloalkyl, heteroarylalkyl, aryl, heteroaryl, cycloalkyl, and —NR9—;
X103, X104, X106, X107, and X108 are each independently selected from bond, —C(R52)2—, —C(O)—, —C(S)—, —P(O)OR9—, —S(O)—, —S(O)2—, —O—, —S—, alkenylene, alkynylene, heterocycle, heteroalkylene, heteroalkynylene, heteroalkenylene, arylalkyl, heterocycloalkyl, heterocycloalkyl, heteroarylalkyl, aryl, heteroaryl, cycloalkyl, and —NR9—; or
R52a is independently selected from R201, halogen, hydroxyl, nitro, cyano, —O(PO)(OR9)2, —(PO)(OR9)2, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, —C2-C6alkenyl-aryl, —C2-C6alkenyl-cycloalkyl-, —C2-C6alkenyl-heterocycle, —C2-C6alkenyl-heteroaryl, —C2-C6alkynyl-aryl, —C2-C6alkynyl-cycloalkyl, —C2-C6alkynyl-heterocycle, —C2-C6alkynyl-heteroaryl, C2-C6alkanoyl, C1-C6alkoxy, C1-C6thioalkyl, —C0-C4alkyl(mono- and di-alkylamino), —C0-C4alkyl(C3-C7cycloalkyl), —C0-C4alkoxy(C3-C7cycloalkyl), C1-C6haloalkyl, C1-C6haloalkoxy, amino, —COOH, —C0-C4alkyl(C3-C7cycloalkyl), C2-C6alkenyloxy, —C(O)OR9, —C0-C4alkylNR9R10, —C(O)NR9R10, —SO2R9, —SO2NR9R10, —OC(O)R9, and —C(NR9)NR9R10;
or R52a and R52 are taken together to form a 3- to 6-membered carbocyclic spiro ring or a 3- to 6-membered heterocyclic spiro ring containing 1 or 2 heteroatoms independently selected from N, O, or S;
or R52a and R52 are taken together to form an oxo or alkenyl group;
C1 is
X1 and X2 are independently N, CH, or CZ, wherein X1 is directly bound to L2 and X2 is directly bound to L1;
Q2 is C(R2R2′);
Q3 is C(R3R3′);
Q4 is C(R1R1′);
Z is F, Cl, NH2, CH3, CH2D, CHD2, or CD3;
R1, R1′, R2, R2′, R3, and R3′ are independently selected from hydrogen, R201, halogen, hydroxyl, nitro, cyano, amino, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, C1-C6alkoxy, C2-C6alkanoyl, C1-C6alkylthio-, hydroxyC1-C6alkyl-, aminoC1-C6alkyl-, —C0-C4alkylNR9R10, —C(O)OR9, —OC(O)R9, —NR9C(O)R10, —C(O)NR9R10, —OC(O)NR9R10, —NR9C(O)OR10, —OR′, —NR′R″, C1-C6haloalkyl, and C1-C6haloalkoxy;
or R1 and R2 are taken together to form a 3-membered carbocyclic ring, a 4- to 6-membered carbocyclic or aryl ring, or a 4- to 6-membered heterocyclic or heteroaryl ring containing 1 or 2 heteroatoms independently selected from N, O, and S;
or R2 and R3 are taken together to form a 3- to 6-membered carbocyclic or aryl ring or a 3- to 6-membered heterocyclic or heteroaryl ring;
R′, and R″ are independently selected from H, R201, alkyl, cycloalkyl, cycloalkylalkyl, heterocycle, heterocycloalkyl, aryl, arylalkyl, heteroaryl, and heteroarylalkyl;
A2 is selected from:
X51, X52, X53 and X54 are selected from N, CR13, and a carbon directly bound to Y9, wherein one and only one of X51, X52, X53 and X54 is a carbon directly bound to Y9;
L1 is a bond,
L2 is —C(O)—, —C(S)—, —P(O)OH—, —S(O)—, —S(O)2—, or —C(R52)2—;
L3 is
X3, X4, X5, X6, X7, and X8 are each independently selected from alkyl, bond, —C(R52)2—, —C(R52)2C(R52)2—, —C(R52)2C(R52)2C(R52)2—, —C(O)—, —C(S)—, —P(O)OR9—, —S(O)—, —S(O)2—, —O—, —S—, R201 in a divalent state, alkenylene, alkynylene, heterocycle, heteroalkylene, heteroalkynylene, heteroalkenylene, arylalkyl, heterocycloalkyl, heteroarylalkyl, aryl, heteroaryl, cycloalkyl, and —NR9—;
X9 and X10 are independently selected from alkylene, —C(R52)2−, —C(R52)2O—, —C(R52)2NR9, —C(R52)2OC(O)—, —C(R2)2NR9C(O)—, —O—, —S—, —C(O)—, —C(S)—, —P(O)OR9—, —S(O)—, —S(O)2—, alkenylene, alkynylene, R201 in a divalent state, R32 in a divalent state, —NR9—, —CH2O—, —CH2N(H)—, —CH2OC(O)—, —CH2N(H)C(O)—, —CH2N(CH3)—, and —CH2N(CH3)C(O)—;
R4, R5, and R6 are independently selected from hydrogen, halogen, —CHO, —C(O)NH2, —C2-C6alkanoyl, —C(O)NH(CH3), —COOH, —P(O)(OR9)2, —OC(O)R9, —C(O)OR9, nitro, hydroxyl, phenyl, 5- to 6-membered heteroaryl, cyano, amino, and C1-C6alkyl;
R7 is hydrogen, C1-C6alkyl, or —C0-C4alkyl(C3-C7cycloalkyl);
R8 and R8′ are independently selected from hydrogen, halogen, hydroxyl, C1-C6alkyl, —C0-C4alkyl(C3-C7cycloalkyl), C1-C6alkoxy, and (C1-C4alkylamino)C0-C2alkyl;
or R8 and R8′ are taken together to form an oxo group;
or R8 and R8′ or taken together to form a 3-membered carbocyclic ring;
R9 and R10 are independently selected at each occurrence from hydrogen, C1-C6alkyl, (C3-C7cycloalkyl)C0-C4alkyl, —C0-C4alkyl(C3-C7cycloalkyl), and —O—C0-C4alkyl(C3-C7cycloalkyl);
R13 is independently selected at each occurrence from hydrogen, R201, halogen, hydroxyl, nitro, cyano, —O(PO)(OR9)2, —(PO)(OR9)2, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, —C2-C6alkenyl-aryl, —C2-C6alkenyl-cycloalkyl, —C2-C6alkenyl-heterocycle, —C2-C6alkenyl-heteroaryl, C2-C6alkynyl, —C2-C6alkynyl-aryl, —C2-C6alkynyl-cycloalkyl, C2-C6alkynyl(heterocycle), —C2-C6alkynyl-heteroaryl, C2-C6alkanoyl, C1-C6alkoxy, C1-C6thioalkyl, —C0-C4alkyl(mono- and di-alkylamino), —C0-C4alkyl(C3-C7cycloalkyl), —C0-C4alkoxy(C3-C7cycloalkyl), C1-C6haloalkyl, C1-C6haloalkoxy, amino, —COOH, —C0-C4alkyl(C3-C7cycloalkyl), C2-C6alkenyloxy, —C(O)OR9, C0-C4alkylNR9R10, —C(O)NR9R10, —SO2R9, —SO2NR9R10, —OC(O)R9, —C(NR9)NR9R10, and R32, each of which other than hydrogen, halogen, hydroxyl, nitro, cyano, haloalkyl, and haloalkoxy is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, amino, —COOH, —CONH2, C1-C6haloalkyl, C1-C6haloalkoxy, phenyl, 4- to 7-membered heterocycle containing 1, 2, or 3 heteroatoms independently selected from N, O, and S, each of which phenyl or 4- to 7-membered heterocycle is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, C1-C6alkyl, C2-C6alkenyl, C2-C6alkanoyl, C1-C6alkoxy, (mono- and di-alkylamino)C0-C4alkyl, C1-C6alkylester, —C0-C4alkyl(C3-C7cycloalkyl), C1-C6haloalkyl, and C1-C6haloalkoxy;
R17 is hydrogen, C1-C6alkyl, or —C0-C4alkyl(C3-C7cycloalkyl);
R18 and R18′ are independently selected from hydrogen, halogen, hydroxymethyl, and methyl;
R21 and R22 are independently selected from hydrogen, hydroxyl, cyano, amino, C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxy, (C3-C7cycloalkyl)C0-C4alkyl, (phenyl)C0-C4alkyl, —C1-C4alkylOC(O)OC1-C6alkyl, —C1-C4alkylOC(O)C1-C6alkyl, —C1-C4alkylC(O)OC1-C6alkyl, (4- to 7-membered heterocycloalkyl)C0-C4alkyl having 1, 2, or 3 heteroatoms independently selected from N, O, and S, and (5- or 6-membered unsaturated or aromatic heterocycle)C0-C4alkyl having 1, 2, or 3 heteroatoms independently selected from N, O, and S;
or R21 and R22 can be taken together to form a carbocyclic or heterocyclic ring;
R23 is independently selected from C1-C6alkyl, C1-C6haloalkyl, (aryl)C0-C4alkyl, (C3-C7cycloalkyl)C0-C4alkyl, (phenyl)C0-C4alkyl, (4- to 7-membered heterocycloalkyl)C0-C4alkyl having 1, 2, or 3 heteroatoms independently selected from N, O, and S, and (5- or 6-membered unsaturated or aromatic heterocycle)C0-C4alkyl having 1, 2, or 3 heteroatoms independently selected from N, O, and S;
R24 and R25 are taken together with the nitrogen to which they are attached to form a 4- to 7-membered monocyclic heterocycloalkyl group, or a 6- to 10-membered bicyclic heterocyclic group having fused, spiro, or bridged rings;
R32 is selected from hydrogen, aryl, heteroaryl, and heterocycle wherein the aryl, heteroaryl, and heterocycle can be optionally substituted with 1, 2, 3, or 4 substituents independently selected from halogen, hydroxyl, amino, cyano, —CHO, —COOH, —CONH2, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, C1-C6alkoxy, C2-C6alkanoyl, C1-C6alkylester, (mono- and di-C1-C6alkylamino)C0-C2alkyl, C1-C6haloalkyl, hydoxyC1-C6alkyl, —C0-C6alkyl-heterocycle, —C0-C6alkyl-heteroaryl, C1-C6haloalkoxy, and R201;
B2 is a heteroaryl, heterocycle, or aryl group directly bound to both L1 and Y10 at two independent positions;
wherein, each of which B2 is optionally substituted with one or more substituents independently selected from R33, R34, R35, R36, and R201;
R33 is independently selected from halogen, hydroxyl, —COOH, cyano, C1-C6alkyl, C2-C6alkanoyl, C1-C6alkoxy, —C0-C4alkylNR9R10, —SO2R9, C1-C6haloalkyl, and C1-C6haloalkoxy;
R34 is independently selected from nitro, C2-C6alkenyl, C2-C6alkynyl, C1-C6thioalkyl, -JC3-C7cycloalkyl, —B(OH)2, -JC(O)NR9R23, -JOSO2OR21, —C(O)(CH2)1-4S(O)R21, —O(CH2)1-4S(O)NR21R22, -JOP(O)(OR21)(OR22), -JP(O)(OR21)(OR22), -JOP(O)(OR21)R22, -JP(O)(OR21)R22, -JOP(O)R21R22, -JP(O)R21R22, -JSP(O)(OR21)(OR22), -JSP(O)(OR21)(R22), -JSP(O)(R21)(R22), -JNR9P(O)(NHR21)(NHR22), -JNR9P(O)(OR21)(NHR22), -JNR9P(O)(OR21)(OR22), -JC(S)R21, -JNR21SO2R22, -JNR9S(O)NR10R22, -JNR9SO2NR10R22, -JSO2NR9COR22, -JSO2NR9CONR21R22, -JNR21SO2R22, -JC(O)NR21SO2R22, -JC(NH2)═NR22, -JCH(NH2)NR9S(O)2R22, -JOC(O)NR21R22, -JNR21C(O)OR22, -JNR21OC(O)R22, —(CH2)1-4C(O)NR21R22, -JC(O)R24R25, -JNR9C(O)R21, -JC(O)R21, -JNR9C(O)NR10R22, —CCR21, —(CH2)1-4OC(O)R21, and -JC(O)OR23; each of which R34 is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, amino, oxo, —B(OH)2, —Si(CH3)3, —COOH, —CONH2, —P(O)(OH)2, C1-C6alkyl, —C0-C4alkyl(C3-C7cycloalkyl), C1-C6alkoxy, —C0-C2alkyl(mono- and di-C1-C4alkylamino), C1-C6alkylester, C1-C4alkylamino, C1-C4hydroxylalkyl, C1-C6haloalkyl, and C1-C6haloalkoxy;
R35 is independently selected from naphthyl, naphthyloxy, indanyl, (4- to 7-membered heterocycloalkyl)C0-C4alkyl containing 1 or 2 heteroatoms selected from N, O, and S, and bicyclic heterocycle containing 1, 2, or 3 heteroatoms independently selected from N, O, and S, and containing 4- to 7-ring atoms in each ring; each of which R35 is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, C1-C6alkyl, C2-C6alkenyl, C2-C6alkanoyl, C1-C6alkoxy, (mono- and di-alkylamino)C0-C4alkyl, C1-C6alkylester, —C0-C4alkyl(C3-C7cycloalkyl), —SO2R, C1-C6haloalkyl, and C1-C6haloalkoxy;
R36 is independently selected from tetrazolyl, (phenyl)C0-C2alkyl, (phenyl)C1-C6alkoxy, phenoxy, and heteroaryl containing 1, 2, or 3 heteroatoms independently selected from N, O, B, and S, each of which R36 is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, C1-C6alkyl, C2-C6alkenyl, C2-C6alkanoyl, C1-C6alkoxy, (mono- and di-alkylamino)C0-C4alkyl, C1-C6alkylester, —C0-C4alkyl(C3-C7cycloalkyl), —SO2R9, —OSi(CH3)2C(CH3)3, —Si(CH3)2C(CH3)3, C1-C6haloalkyl, and C1-C6haloalkoxy;
R52 is independently selected from halo, hydrogen, or C1-C6alkyl, amino, hydroxyl, aminoalkyl, alkenyl, alkynyl, C2-C6alkenyl(aryl), C2-C6alkenyl(cycloalkyl), C2-C6alkenyl(heterocycle), C2-C6alkenyl(heteroaryl), alkynyl, C2-C6alkynyl(aryl), C2-C6alkynyl(cycloalkyl), C2-C6alkynyl(heterocycle), C2-C6alkynyl(heteroaryl), alkanoyl, C1-C6alkoxy, C1-C6thioalkyl, —C0-C4alkyl(mono- and di-alkylamino), —C0-C4alkyl(C3-C7cycloalkyl), —C0-C4alkoxy(C3-C7cycloalkyl), haloalkyl, haloalkoxy, —COOH, —C0-C4alkyl(C3-C7cycloalkyl), C2-C6alkenyloxy, —C(O)OR9, —C0-C4alkylNR9R10, —C(O)NR9R10, —SO2R9, —SO2NR9R10, —OC(O)R9, R201, and N(R9)C(o)R10;
or two R52 groups can be taken together to form an oxo or alkene group;
or two R52 groups can be taken together to form a 3- to 6-membered carbocyclic spiro ring or a 3- to 6-membered heterocyclic spiro ring containing 1 or 2 heteroatoms independently selected from N, O, or S;
R201 is selected from aminoalkyl-, alkylaminoalkyl-, heterocycloalkyl-, hydroxyalkyl, -alkyl-O-alkyl, -alkyl-S-alkyl, -alkyl-N(alkyl)-alkyl, -alkyl-NH-alkyl, -aliphatic-O-aliphatic, -aliphatic-S-aliphatic, -aliphatic-N(aliphatic)-aliphatic, -aliphatic-NH-aliphatic, -aliphatic-O-heterocycle, -aliphatic-S-heterocycle, -aliphatic-N(aliphatic)-heterocycle, -aliphatic-NH-heterocycle, -alkyl-NHC(O)haloalkyl, -alkyl-NR9C(O)haloalkyl, -alkyl-C(O)NHhaloalkyl, -alkyl-C(O)NR9haloalkyl, -alkyl-NHC(O)haloalkyl, -alkyl-NR9C(O)aliphatic, -alkyl-C(O)NHaliphatic, -alkyl-NR9C(O)aliphatic, -alkyl-NHC(O)aliphatic, alkyl-O-haloalkyl, alkyl-heteroaryl, heteroaryl, heterocycle, alkyl-heterocycle, and —N(aliphatic)2;
J is independently selected from a covalent bond, C1-C4alkylene, —OC1-C4alkylene, C2-C4alkenylene, and C2-C4alkynylene; and
m is 0, 1, 2, or 3.

### Claim 15 (depends on 14)

The compound of claim 14, wherein R32 is

### Claim 16 (depends on 14)

The compound of claim 14, wherein X9-L3-X10 or X10-L3-X9 is selected from:

### Claim 17 (depends on 14)

The compound of claim 14, wherein X9-L3-X10 or X10-L3-X9 is selected from:

### Claim 18 (depends on 14)

The compound of claim 14, wherein B2 is a six membered heteroaryl substituted with 1 or 2 groups selected from R33.

### Claim 19 (depends on 14)

A pharmaceutical composition comprising a compound of claim 14 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

### Claim 20

A compound selected from Formula:
or a pharmaceutically acceptable salt thereof;
wherein:
C1 is
X1 and X2 are independently N, CH, or CZ, wherein X1 is directly bound to L2 and X2 is directly bound to L1;
Q2 is C(R2R2′);
Q3 is C(R3R3′);
Q4 is C(R1R1′);
Z is F, Cl, NH2, CH3, CH2D, CHD2, or CD3;
R1, R1′, R2, R2′, R3, and R3′ are independently selected from hydrogen, R201, halogen, hydroxyl, nitro, cyano, amino, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, C1-C6alkoxy, C2-C6alkanoyl, C1-C6alkylthio-, hydroxyC1-C6alkyl-, aminoC1-C6alkyl-, —C0-C4alkylNR9R10, —C(O)OR9, —OC(O)R9, —NR9C(O)R10, —C(O)NR9R10, —OC(O)NR9R10, —NR9C(O)OR10, —OR′, —NR′R″, C1-C6haloalkyl, and C1-C6haloalkoxy;
or R1 and R2 are taken together to form a 3-membered carbocyclic ring, a 4- to 6-membered carbocyclic or aryl ring, or a 4- to 6-membered heterocyclic or heteroaryl ring containing 1 or 2 heteroatoms independently selected from N, O, and S;
or R2 and R3 are taken together to form a 3- to 6-membered carbocyclic or aryl ring or a 3- to 6-membered heterocyclic or heteroaryl ring;
R, R′, and R″ are independently selected from H, R201, alkyl, cycloalkyl, cycloalkylalkyl, heterocycle, heterocycloalkyl, aryl, arylalkyl, heteroaryl, and heteroarylalkyl;
C3 is
wherein one of R1, R2, R3, R1′, R2′, or R3′ is replaced with a direct bond to X9, and wherein one of R1, R2, R3, R1′, R2′, or R3′ is replaced with a direct bond to X10;
C4 is
wherein C4 is directly bound to X9, X10, L1, and L2, wherein X9 and/or X10 can be directly bound to C4, or X9 and/or X10 can be bound to a ring resulting from the cyclization of R1, R2, R3, R1′, R2′, or R3′, as defined above;
A1 is selected from:
A3 is selected from:
wherein X51, X52, X53 and X54 are selected from N, CR13, a carbon directly bound to X9, and a carbon directly bound to X10, and wherein one and only one of X51, X52, X53 and X54 is a carbon directly bound to X9, and wherein one and only one of X51, X52, X53 and X54 is a carbon directly bound to X10, and wherein X9 and X10 are linked to L3;
L1 is a bond,
L2 is —C(O)—, —C(S)—, —P(O)OH—, —S(O)—, —S(O)2—, or —C(R52)2—;
L3 is
X3, X4, X5, X6, X7, and X8 are each independently selected from alkyl, bond, —C(R52)2—, —C(R52)2C(R52)2—, —C(R52)2C(R52)2C(R52)2—, —C(O)—, —C(S)—, —P(O)OR9—, —S(O)—, —S(O)2—, —O—, —S—, R201 in a divalent state, alkenylene, alkynylene, heterocycle, heteroalkylene, heteroalkynylene, heteroalkenylene, arylalkyl, heterocycloalkyl, heteroarylalkyl, aryl, heteroaryl, cycloalkyl, and —NR9—;
X9 and X10 are independently selected from alkylene, —C(R32)2−, —C(R52)2O—, —C(R52)2NR9—, —C(R52)2OC(O)—, —C(R52)2NR9C(O)—, —O—, —S—, —C(O)—, —C(S)—, —P(O)OR9—, —S(O)—, —S(O)2—, alkenylene, alkynylene, R201 in a divalent state, R32 in a divalent state, —NR9—, —CH2O—, —CH2N(H)—, —CH2OC(O)—, —CH2N(H)C(O)—, —CH2N(CH3)—, and —CH2N(CH3)C(O)—;
X11 is N or CR11;
X12 is N or CR12;
X13 is N or CR13,
X14 is N or CR14;
wherein no more than 2 of X11, X12, X13, and X14 are N;
R4, R5, and R6 are independently selected from hydrogen, halogen, —CHO, —C(O)NH2, —C2-C6alkanoyl, —C(O)NH(CH3), —COOH, —P(O)(OR9)2, —OC(O)R9, —C(O)OR9, nitro, hydroxyl, phenyl, 5- to 6-membered heteroaryl, cyano, amino, and C1-C6alkyl;
R7 is hydrogen, C1-C6alkyl, or —C0-C4alkyl(C3-C7cycloalkyl);
R8 and R8′ are independently selected from hydrogen, halogen, hydroxyl, C1-C6alkyl, —C0-C4alkyl(C3-C7cycloalkyl), C1-C6alkoxy, and (C1-C4alkylamino)C0-C2alkyl;
or R8 and R8′ are taken together to form an oxo group;
or R9 and R10 or taken together to form a 3-membered carbocyclic ring;
R9 and R10 are independently selected at each occurrence from hydrogen, C1-C6alkyl, (C3-C7cycloalkyl)C0-C4alkyl, —C0-C4alkyl(C3-C7cycloalkyl), and —O—C0-C4alkyl(C3-C7cycloalkyl);
R11, R12, R13, and R14 are independently selected at each occurrence from hydrogen, R201, halogen, hydroxyl, nitro, cyano, —O(PO)(OR)2, —(PO)(OR9)2, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, —C2-C6alkenyl-aryl, —C2-C6alkenyl-cycloalkyl, —C2-C6alkenyl-heterocycle, —C2-C6alkenyl-heteroaryl, C2-C6alkynyl, —C2-C6alkynyl-aryl, —C2-C6alkynyl-cycloalkyl, C2-C6alkynyl(heterocycle), —C2-C6alkynyl-heteroaryl, C2-C6alkanoyl, C1-C6alkoxy, C1-C6thioalkyl, —C0-C4alkyl(mono- and di-alkylamino), —C0-C4alkyl(C3-C7cycloalkyl), —C0-C4alkoxy(C3-C7cycloalkyl), C0-C6haloalkyl, C0-C6haloalkoxy, amino, —COOH, —C0-C4alkyl(C3-C7cycloalkyl), C2-C6alkenyloxy, —C(O)OR9, C0-C4alkylNR9R10, —C(O)NR9R10, —SO2R9, —SO2NR9R10, —OC(O)R9, —C(NR9)NR9R10, and R32, each of which other than hydrogen, halogen, hydroxyl, nitro, cyano, haloalkyl, and haloalkoxy is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, amino, —COOH, —CONH2, C1-C6haloalkyl, C1-C6haloalkoxy, phenyl, 4- to 7-membered heterocycle containing 1, 2, or 3 heteroatoms independently selected from N, O, and S, each of which phenyl or 4- to 7-membered heterocycle is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, C1-C6alkyl, C2-C6alkenyl, C2-C6alkanoyl, C1-C6alkoxy, (mono- and di-alkylamino)C0-C4alkyl, C1-C6alkylester, —C0-C4alkyl(C3-C7cycloalkyl), C1-C6haloalkyl, and C1-C6haloalkoxy;
R17 is hydrogen, C1-C6alkyl, or —C0-C4alkyl(C3-C7cycloalkyl);
R18 and R18′ are independently selected from hydrogen, halogen, hydroxymethyl, and methyl;
R21 and R22 are independently selected from hydrogen, hydroxyl, cyano, amino, C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxy, (C3-C7cycloalkyl)C0-C4alkyl, (phenyl)C0-C4alkyl, —C1-C4alkylOC(O)OC1-C6alkyl, —C1-C4alkylOC(O)C1-C6alkyl, —C1-C4alkylC(O)OC1-C6alkyl, (4- to 7-membered heterocycloalkyl)C0-C4alkyl having 1, 2, or 3 heteroatoms independently selected from N, O, and S, and (5- or 6-membered unsaturated or aromatic heterocycle)C0-C4alkyl having 1, 2, or 3 heteroatoms independently selected from N, O, and S;
or R21 and R22 can be taken together to form a carbocyclic or heterocyclic ring;
R23 is independently selected from C1-C6alkyl, C1-C6haloalkyl, (aryl)C0-C4alkyl, (C3-C7cycloalkyl)C0-C4alkyl, (phenyl)C0-C4alkyl, (4- to 7-membered heterocycloalkyl)C0-C4alkyl having 1, 2, or 3 heteroatoms independently selected from N, O, and S, and (5- or 6-membered unsaturated or aromatic heterocycle)C0-C4alkyl having 1, 2, or 3 heteroatoms independently selected from N, O, and S;
R24 and R25 are taken together with the nitrogen to which they are attached to form a 4- to 7-membered monocyclic heterocycloalkyl group, or a 6- to 10-membered bicyclic heterocyclic group having fused, spiro, or bridged rings;
R32 is selected from hydrogen, aryl, heteroaryl, and heterocycle wherein the aryl, heteroaryl, and heterocycle can be optionally substituted with 1, 2, 3, or 4 substituents independently selected from halogen, hydroxyl, amino, cyano, —CHO, —COOH, —CONH2, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, C1-C6alkoxy, C2-C6alkanoyl, C1-C6alkylester, (mono- and di-C1-C6alkylamino)C0-C2alkyl, C1-C6haloalkyl, hydoxyC1-C6alkyl, —C0-C6alkyl-heterocycle, —C0-C6alkyl-heteroaryl, C1-C6haloalkoxy, and R201;
B1 is heteroaryl, heterocycle, aryl, monocyclic or bicyclic carbocycle, C2-C6alkenyl, C2-C6alkynyl, biphenyl, or alkyl; wherein, each of which B1 is optionally substituted with one or more substituents independently selected from R33, R34, R35, R36, and R201;
B3 is heteroaryl, heterocycle, or aryl, each of which B3 is directly bound to L1, X9, and X10 at three independent positions; wherein, each of which B3 is optionally substituted with one or more substituents independently selected from R33, R34, R35, R36, and R201;
R33 is independently selected from halogen, hydroxyl, —COOH, cyano, C1-C6alkyl, C2-C6alkanoyl, C1-C6alkoxy, —C0-C4alkylNR9R10, —SO2R9, C1-C6haloalkyl, and C1-C6haloalkoxy;
R34 is independently selected from nitro, C2-C6alkenyl, C2-C6alkynyl, C1-C6thioalkyl, -JC3-C7cycloalkyl, —B(OH)2, -JC(O)NR9R23, -JOSO2OR21, —C(O)(CH2)1-4S(O)R21, —O(CH2)1-4S(O)NR21R22, -JOP(O)(OR21)(OR22), -JP(O)(OR21)(OR22), -JOP(O)(OR21)R22, -JP(O)(OR21)R22, -JOP(O)R21R22, -JP(O)R21R22, -JSP(O)(OR21)(OR22), -JSP(O)(OR21)(R22), -JSP(O)(R21)(R22), -JNR9P(O)(NHR21)(NHR22), -JNR9P(O)(OR21)(R22), -JNR9P(O)(OR21)(OR22), -JC(S)R21, -JNR21SO2R22, -JNR9S(O)NR10R22, -JNR9SO2NR10R22, -JSO2NR9COR22, -JSO2NR9CONR21R22, -JNR21SO2R22, -JC(O)NR21SO2R22, -JC(NH2)═NR22, -JCH(NH2)NR9S(O)2R22, -JOC(O)NR21R21R22, -JNR21C(O)OR22, -JNR21OC(O)R22, —(CH2)1-4C(O)NR21R22, -JC(O)R24R25, -JNR9C(O)R21, -JC(O)R21, -JNR9C(O)NR10R22, —CCR21, —(CH2)1-4OC(O)R21, and -JC(O)OR23; each of which R34 is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, amino, oxo, —B(OH)2, —Si(CH3)3, —COOH, —CONH2, —P(O)(OH)2, C1-C6alkyl, —C0-C4alkyl(C3-C7cycloalkyl), C1-C6alkoxy, —C0-C2alkyl(mono- and di-C1-C4alkylamino), C1-C6alkylester, C1-C4alkylamino, C1-C4hydroxylalkyl, C1-C6haloalkyl, and C1-C6haloalkoxy;
R35 is independently selected from naphthyl, naphthyloxy, indanyl, (4- to 7-membered heterocycloalkyl)C0-C4alkyl containing 1 or 2 heteroatoms selected from N, O, and S, and bicyclic heterocycle containing 1, 2, or 3 heteroatoms independently selected from N, O, and S, and containing 4- to 7-ring atoms in each ring; each of which R35 is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, C1-C6alkyl, C2-C6alkenyl, C2-C6alkanoyl, C1-C6alkoxy, (mono- and di-alkylamino)C0-C4alkyl, C1-C6alkylester, —C0-C4alkyl(C3-C7cycloalkyl), —SO2R9, C1-C6haloalkyl, and C1-C6haloalkoxy;
R36 is independently selected from tetrazolyl, (phenyl)C0-C2alkyl, (phenyl)C1-C6alkoxy, phenoxy, and heteroaryl containing 1, 2, or 3 heteroatoms independently selected from N, O, B, and S, each of which R36 is optionally substituted with one or more substituents independently selected from halogen, hydroxyl, nitro, cyano, C1-C6alkyl, C2-C6alkenyl, C2-C6alkanoyl, C1-C6alkoxy, (mono- and di-alkylamino)C0-C4alkyl, C1-C6alkylester, —C0-C4alkyl(C3-C7cycloalkyl), —SO2R9, —OSi(CH3)2C(CH3)3, —Si(CH3)2C(CH3)3, C1-C6haloalkyl, and C1-C6haloalkoxy;
R12 is independently selected from halo, hydrogen, or C1-C6alkyl, amino, hydroxyl, aminoalkyl, alkenyl, alkynyl, C2-C6alkenyl(aryl), C2-C6alkenyl(cycloalkyl), C2-C6alkenyl(heterocycle), C2-C6alkenyl(heteroaryl), alkynyl, C2-C6alkynyl(aryl), C2-C6alkynyl(cycloalkyl), C2-C6alkynyl(heterocycle), C2-C6alkynyl(heteroaryl), alkanoyl, C1-C6alkoxy, C1-C6thioalkyl, —C0-C4alkyl(mono- and di-alkylamino), —C0-C4alkyl(C3-C7cycloalkyl), —C0-C4alkoxy(C3-C7cycloalkyl), haloalkyl, haloalkoxy, —COOH, —C0-C4alkyl(C3-C7cycloalkyl), C2-C6alkenyloxy, —C(O)OR9, —C0-C4alkylNR9R10, —C(O)NR9R10, —SO2R9, —SO2NR9R10, —OC(O)R9, R201, and N(R9)C(O)R10;
or two R52 groups can be taken together to form an oxo or alkene group;
or two R52 groups can be taken together to form a 3- to 6-membered carbocyclic spiro ring or a 3- to 6-membered heterocyclic spiro ring containing 1 or 2 heteroatoms independently selected from N, O, or S;
R201 is selected from aminoalkyl-, alkylaminoalkyl-, heterocycloalkyl-, hydroxyalkyl, -alkyl-O-alkyl -alkyl-S-alkyl, -alkyl-N(alkyl)-alkyl, -alkyl-NH-alkyl, -aliphatic-O-aliphatic, -aliphatic-S-aliphatic, -aliphatic-N(aliphatic)-aliphatic, -aliphatic-NH-aliphatic, -aliphatic-O-heterocycle, -aliphatic-S-heterocycle, -aliphatic-N(aliphatic)-heterocycle, -aliphatic-NH-heterocycle, -alkyl-NHC(O)haloalkyl, -alkyl-NR9C(O)haloalkyl, -alkyl-C(O)NHhaloalkyl, -alkyl-C(O)NR9haloalkyl, -alkyl-NHC(O)haloalkyl, -alkyl-NR9C(O)aliphatic, -alkyl-C(O)NHaliphatic, -alkyl-NR9C(O)aliphatic, -alkyl-NHC(O)aliphatic, alkyl-O-haloalkyl, alkyl-heteroaryl, heteroaryl, heterocycle, alkyl-heterocycle, and —N(aliphatic)2;
J is independently selected from a covalent bond, C1-C4alkylene, —OC1-C4alkylene, C2-C4alkenylene, and C2-C4alkynylene; and
m is 0, 1, 2, or 3.

### Claim 21 (depends on 20)

The compound of claim 20, wherein R32 is

### Claim 22 (depends on 20)

The compound of claim 20, wherein X9-L3-X10 or X10-L3-X9 is selected from:

### Claim 23 (depends on 20)

The compound of claim 20, wherein X9-L3-X10 or X10-L3-X9 is selected from:

### Claim 24 (depends on 20)

The compound of claim 20, wherein B1 is a six membered heteroaryl substituted with 1, 2, or 3 groups selected from R33.

### Claim 25 (depends on 20)

A pharmaceutical composition comprising a compound of claim 20 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
